Meeting Banner
Abstract #3797

Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Receptor Agonist, Protects the Rat Heart Against Ischemia/reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency

Hasan Alsaid1, Weike Bao2, Thimmaiah Chendrimada2, Matthew Szapacs3, David R. Citerone3, Mark R. Harpel2, Robert N. Willette2, John J. Lepore2, Beat M. Jucker1

1Preclinical & Translational Imaging, GlaxoSmithKline, King of Prussia, PA, United States; 2Heart Failure DPU, GlaxoSmithKline, King of Prussia, PA, United States; 3Platform Technology and Science, GlaxoSmithKline, King of Prussia, PA, United States

Albiglutide is a novel GLP-1 analog in clinical development for Type 2 diabetes. In the present study, albiglutide was shown to reduce myocardial infarct size and improved post-ischemic cardiac function and energetics by combined in vivo MRI/MRS following myocardial I/R injury. The observed benefits were associated with enhanced myocardial glucose uptake and shift toward a more energetically favorable substrate metabolism profile by increasing both glucose and lactate oxidation as assessed by ex vivo MRS. These findings suggest that in addition to providing peripheral glycemic control, albiglutide may have direct therapeutic potential for improving cardiac energetic and function in the setting of myocardial ischemic injury.

Abstract PDF

Keywords

absolute acid acting acute additionally animals anterior artery assessed awake beat carbohydrate carbon cardiac cine clamp coil combination concentration concentrations concentric conditions continuous contribution cover currently cycle days delays dependent descending dimensions direct directly dose double efficiency efflux ejection energetic energetics enhanced enrichments evidence examine examined external extracts extrapolated failure fatty findings fraction free function generated glucose glycogen heart hypothesis immediately improving in vivo increasing infarct infusion injury john jugular ketone king lactate lasting like long loop manner mark matrix metabolic metabolite myocardial normalized oblique observe occlusion orthogonal outer oxidation part peptide platform pool positioned post potential preserving previously profile protect protects proton rats receptor reduced reducing repetition science selected separate setting sham significantly slice spectrometer spectroscopic spectroscopy subjected substrate sufficient suggest suppression surface system technology terms therapeutic tissue translational treated tune units unknown uptake utilization vehicle vein ventricle ventricles versus volume